AWEBB Competitors

UCL (University College London) is London's leading multidisciplinary university, ranked 9th in the QS World University Rankings. Established in 1826 UCL opened up education in England for the first time to students of any race, class or religion and was also the first university to welcome female students on equal terms with men. Today UCL is made up of remarkable people: eminent professors and exceptional students. Academic excellence and conducting research that addresses real-world problems inform our ethos to this day. To see more photos of UCL you can visit our Flickr Gallery: www.flickr.com/photos/uclnews/sets/ To view videos of UCL and our work, you can subscribe to our YouTube Channel: http://www.youtube.com/user/UCLTV Looking for a job at UCL? Find out more about working with us and view the latest vacancies: https://www.ucl.ac.uk/jobs

Techstars helps founders scale their startups into world-changing businesses. Founded in 2006, Techstars is on a mission to invest in startups to enable more capital to flow to more entrepreneurs around the world in order to deliver exceptional returns to our investors. We do this by operating accelerator programs and venture capital funds, as well as by connecting startups, investors, corporations, and cities to help build thriving startup communities. Our results show why Techstars is Better for Founders than any other global accelerator: On average, 74.5% of Techstars companies will raise money within 3 years of their program; 18.5% of Techstars portfolio companies have exited 5 years after their program and 31.1% after eight years. (PitchBook June 2023)

The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.